Nanbu_2018_Oncol.Rep_39_367

Reference

Title : Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells - Nanbu_2018_Oncol.Rep_39_367
Author(s) : Nanbu T , Umemura N , Ohkoshi E , Nanbu K , Sakagami H , Shimada J
Ref : Oncol Rep , 39 :367 , 2018
Abstract : Nanbu_2018_Oncol.Rep_39_367
ESTHER : Nanbu_2018_Oncol.Rep_39_367
PubMedSearch : Nanbu_2018_Oncol.Rep_39_367
PubMedID: 29192320

Related information

Citations formats

Nanbu T, Umemura N, Ohkoshi E, Nanbu K, Sakagami H, Shimada J (2018)
Combined SN-38 and gefitinib treatment promotes CD44 degradation in head and neck squamous cell carcinoma cells
Oncol Rep 39 :367

Nanbu T, Umemura N, Ohkoshi E, Nanbu K, Sakagami H, Shimada J (2018)
Oncol Rep 39 :367